{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:03:11Z","timestamp":1790683391671,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZB20240038"],"award-info":[{"award-number":["GZB20240038"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M781685"],"award-info":[{"award-number":["2025M781685"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["COHF-KQZS2026023"],"award-info":[{"award-number":["COHF-KQZS2026023"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Dental Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.identj.2026.109674","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:29:59Z","timestamp":1781638199000},"page":"109674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meta-Analysis and Systematic Review of Immune Checkpoint Expression in Predicting the Risk of Malignant Transformation in Oral Potentially Malignant Disorders"],"prefix":"10.1016","volume":"76","author":[{"given":"Yingying","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-7474","authenticated-orcid":false,"given":"Xinjia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0001","article-title":"Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022","volume":"76","author":"Rumgay","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.identj.2026.109674_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105661","article-title":"Clinical and prognostic features of multiple primary cancers with oral squamous cell carcinoma","volume":"149","author":"Cai","year":"2023","journal-title":"Arch Oral Biol"},{"issue":"7","key":"10.1016\/j.identj.2026.109674_bib0003","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/odi.13147","article-title":"Distant metastases in newly diagnosed tongue squamous cell carcinoma","volume":"25","author":"Cai","year":"2019","journal-title":"Oral Dis"},{"issue":"8","key":"10.1016\/j.identj.2026.109674_bib0004","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating centre for oral cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis"},{"issue":"10","key":"10.1016\/j.identj.2026.109674_bib0005","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1002\/lary.32236","article-title":"Malignant transformation rate of oral premalignant disorders: a large database analysis","volume":"135","author":"Meci","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.identj.2026.109674_bib0006","article-title":"Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder","author":"Lorezo-Pouso","year":"2022","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.identj.2026.109674_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105462","article-title":"Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit","volume":"121","author":"Gilvetti","year":"2021","journal-title":"Oral Oncol"},{"key":"10.1016\/j.identj.2026.109674_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105619","article-title":"Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders","volume":"123","author":"Cai","year":"2021","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.identj.2026.109674_bib0009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hed.26006","article-title":"Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype","volume":"42","author":"Iocca","year":"2020","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.109342","article-title":"Scientific mapping and knowledge evolution of global areca research","volume":"76","author":"Ding","year":"2026","journal-title":"Int dent j"},{"key":"10.1016\/j.identj.2026.109674_bib0011","article-title":"Oral epithelial dysplasia grading: comparing the binary system to the traditional 3-tier system, an actuarial study with malignant transformation as outcome","author":"Sperandio","year":"2022","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"10.1016\/j.identj.2026.109674_bib0012","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/odi.13993","article-title":"Oral epithelial dysplasia: Recognition, grading and clinical significance","volume":"27","author":"Odell","year":"2021","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/prd.12259","article-title":"Oral epithelial dysplasia: causes, quantification, prognosis, and management challenges","volume":"80","author":"Tilakaratne","year":"2019","journal-title":"Periodontol 2000"},{"issue":"5","key":"10.1016\/j.identj.2026.109674_bib0014","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/odi.14809","article-title":"Architectural and cytological features of epithelial dysplasia associated with transformation risk","volume":"30","author":"Cai","year":"2024","journal-title":"Oral Dis"},{"issue":"5","key":"10.1016\/j.identj.2026.109674_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jop.13632","article-title":"Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review of the past 4\u2009years","volume":"54","author":"Monteiro","year":"2025","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"10.1016\/j.identj.2026.109674_bib0016","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/odi.13747","article-title":"Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review","volume":"27","author":"Monteiro","year":"2021","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.identj.2026.109674_bib0017","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/odi.13363","article-title":"World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies","volume":"27","author":"Celentano","year":"2021","journal-title":"Oral Dis"},{"key":"10.1016\/j.identj.2026.109674_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-Then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.identj.2026.109674_bib0019","article-title":"Immunosurveillance in clinical cancer management","author":"Kroemer","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.identj.2026.109674_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2024.1143","article-title":"Intensity-modulated reirradiation therapy with nivolumab in recurrent or second primary head and neck squamous cell carcinoma: a nonrandomized controlled trial","author":"Saba","year":"2024","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.identj.2026.109674_bib0021","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.109348","article-title":"Nanoplatform-enhanced photodynamic therapy in head and neck squamous cell carcinoma: advances and future directions","volume":"76","author":"Zhang","year":"2026","journal-title":"Int Dent J"},{"issue":"6","key":"10.1016\/j.identj.2026.109674_bib0023","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/carcin\/bgab035","article-title":"PD-1 blockade prevents the progression of oral carcinogenesis","volume":"42","author":"Dong","year":"2021","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.identj.2026.109674_bib0024","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pathol.2021.09.013","article-title":"PD-1\/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma","volume":"54","author":"Kujan","year":"2022","journal-title":"Pathology"},{"issue":"8","key":"10.1016\/j.identj.2026.109674_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100173","article-title":"Development of a pathomics-based model for the prediction of malignant transformation in oral leukoplakia","volume":"103","author":"Cai","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.identj.2026.109674_bib0026","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.identj.2026.109674_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2026.109453","article-title":"Inflammatory biomarkers in irreversible pulpitis and pulp necrosis: a systematic review and meta-analysis","volume":"76","author":"Wahyudi","year":"2026","journal-title":"Int Dent J"},{"issue":"6","key":"10.1016\/j.identj.2026.109674_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.103944","article-title":"Human papillomavirus infection as a risk factor for oral leukoplakia: a systematic review and meta-analysis","volume":"75","author":"Taha","year":"2025","journal-title":"Int Dent J"},{"issue":"4","key":"10.1016\/j.identj.2026.109674_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.identj.2026.109674_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.34607","article-title":"Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort","author":"William","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.identj.2026.109674_bib0031","article-title":"Influence of PD-1\/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma","volume":"10","author":"Xu","year":"2022","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.identj.2026.109674_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250359","article-title":"Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: a retrospective cohort study","volume":"16","author":"Yagyuu","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.identj.2026.109674_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020194","article-title":"Importance of the PD-1\/PD-L1 axis for malignant transformation and risk assessment of oral leukoplakia","volume":"9","author":"Ries","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.identj.2026.109674_bib0034","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.oraloncology.2017.03.006","article-title":"Programmed death ligand 1 (PD-L1) expression and tumour microenvironment: Implications for patients with oral precancerous lesions","volume":"68","author":"Yagyuu","year":"2017","journal-title":"Oral Oncol"},{"issue":"7658","key":"10.1016\/j.identj.2026.109674_bib0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/bmj.a117","article-title":"Reasons or excuses for avoiding meta-analysis in forest plots","volume":"336","author":"Ioannidis","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.identj.2026.109674_bib0036","article-title":"Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: a systematic review and meta-analysis","author":"Monteiro","year":"2022","journal-title":"Oral Dis"},{"key":"10.1016\/j.identj.2026.109674_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102986","article-title":"Oral potentially malignant disorders: a scoping review of prognostic biomarkers","volume":"153","author":"Mello","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.identj.2026.109674_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105734","article-title":"Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: a systematic review and meta-analysis","volume":"126","author":"Ramos-Garcia","year":"2022","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.identj.2026.109674_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/biom12050606","article-title":"Podoplanin expression independently and jointly with oral epithelial dysplasia grade acts as a potential biomarker of malignant transformation in oral leukoplakia","volume":"12","author":"Monteiro","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.identj.2026.109674_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071937","article-title":"Immune checkpoint inhibitors in oral cavity squamous cell carcinoma and oral potentially malignant disorders: a systematic review","volume":"12","author":"Kujan","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0041","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","article-title":"Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma","volume":"13","author":"Elmusrati","year":"2021","journal-title":"Int J Oral Sci"},{"issue":"9","key":"10.1016\/j.identj.2026.109674_bib0042","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/apm.12881","article-title":"CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma","volume":"126","author":"Stasikowska-Kanicka","year":"2018","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.identj.2026.109674_bib0043","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jop.13434","article-title":"The preliminary exploration of immune microenvironment in oral leukoplakia concomitant with oral submucosal fibrosis: a comparative immunohistochemical study","volume":"52","author":"Cai","year":"2023","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0044","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jop.13250","article-title":"Characterization and function of circulating mucosal-associated invariant T cells and \u03b3\u03b4T cells in oral lichen planus","volume":"51","author":"Yang","year":"2022","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/prd.12277","article-title":"Oral submucous fibrosis: a global challenge. Rising incidence, risk factors, management, and research priorities","volume":"80","author":"Ray","year":"2019","journal-title":"Periodontol 2000"},{"issue":"19","key":"10.1016\/j.identj.2026.109674_bib0046","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022655118","article-title":"Immune evasion in HPV(-) head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss","volume":"118","author":"William","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0047","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaoncol.2023.4853","article-title":"Nivolumab for patients with high-risk oral leukoplakia: a nonrandomized controlled trial","volume":"10","author":"Hanna","year":"2024","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.identj.2026.109674_bib0048","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/00220345231217160","article-title":"Copy number alterations predict development of OSCC from oral leukoplakia","volume":"103","author":"Cai","year":"2024","journal-title":"J Dent Res"},{"issue":"4","key":"10.1016\/j.identj.2026.109674_bib0049","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s43018-023-00533-y","article-title":"Inferring early genetic progression in cancers with unobtainable premalignant disease","volume":"4","author":"Leshchiner","year":"2023","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.identj.2026.109674_bib0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1078-0432.CCR-22-2210","article-title":"Elucidating the genetic landscape of oral leukoplakia to predict malignant transformation","volume":"29","author":"Wils","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0051","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/JS9.0000000000002077","article-title":"Identification of genomic alteration and prognosis using pathomics-based artificial intelligence in oral leukoplakia and head and neck squamous cell carcinoma: a multicenter experimental study","volume":"111","author":"Cai","year":"2025","journal-title":"Int J Surg (Lond Engl)"},{"issue":"1","key":"10.1016\/j.identj.2026.109674_bib0052","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12885-021-08297-3","article-title":"Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial","volume":"21","author":"Gurizzan","year":"2021","journal-title":"Bmc Cancer"}],"container-title":["International Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:32:06Z","timestamp":1790681526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020653926002674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0020653926002674"],"URL":"https:\/\/doi.org\/10.1016\/j.identj.2026.109674","relation":{},"ISSN":["0020-6539"],"issn-type":[{"value":"0020-6539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis and Systematic Review of Immune Checkpoint Expression in Predicting the Risk of Malignant Transformation in Oral Potentially Malignant Disorders","name":"articletitle","label":"Article Title"},{"value":"International Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.identj.2026.109674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.","name":"copyright","label":"Copyright"}],"article-number":"109674"}}